When will Telescope Innovations (TELI.CN) report earnings?

Telescope Innovations (TELI.CN) announces earnings on **Jan 26 2026** at **16:00 EST**. Expect commentary on R&D progress, revenue trends, and any licensing updates that could move TELI.CN stock.

What is the current valuation of TELI.CN stock?

TELI.CN stock trades at **C$0.44** with EPS **-0.03**, PE **-14.67**, P/S **6.28**, and P/B **11.38**. These metrics indicate a small-cap biotech priced for future growth, with elevated valuation risk today.

How does Meyka AI view TELI.CN stock?

Meyka AI rates TELI.CN with a score out of 100: **57.74** (Grade **C+**, Suggestion: **HOLD**). The grade reflects benchmark, sector, growth, metrics, and analyst signals and is informational only.

What price moves could follow the Jan 26 earnings for TELI.CN stock?

Short-term swings could be large given average volume **133,853.00** and current liquidity. Meyka forecasts a monthly **C$0.45** (+**2.27%**) and yearly **C$0.38** (-**12.84%**). Positive news could push toward **C$0.60**; negative news could test **C$0.30**

CA Stocks

TELI.CN Telescope Innovations Corp. (CNQ) earnings Jan 26 2026: key catalysts

ByDanny Kontos January 21, 2026January 21, 2026

The most important fact for investors: TELI.CN stock trades at C$0.44 ahead of an earnings announcement scheduled for Jan 26 2026. Volume today is 83,830.00 shares versus a 50-day average of 133,853.00, indicating below-average trading ahead of the report. The Healthcare biotechnology name shows a recent 1-month gain of 39.68%, but the company still posts negative EPS of -0.03 and a negative PE of -14.67. We outline the earnings catalysts, valuation context, Meyka AI grade, and short-term price scenarios to help frame risk and opportunity for TELI.CN stock